ArticleScientific reports2017

Bisphosphonates enhance antitumor effect of EGFR-TKIs in patients with advanced EGFR mutant NSCLC and bone metastases.

Guowei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.